TMCnet News
World Stroke Diagnostics & Therapeutics Market Report 2014-2022 - Analysis, Technologies & Forecasts - Research and MarketsResearch and Markets has announced the addition of the "World Stroke Diagnostics and Therapeutics Market - Opportunities and Forecasts, 2014 - 2022" report to their offering. The global stroke diagnostic and therapeutic market, is segmented on the basis of type, application and geography. According to type, the market is segmented into diagnostics and therapeutics. Diagnostic market is further sub-segmented into Computed Tomography Scan (CT scan), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography and others. Therapeutic market is further sub-segmented into Tissue Plasminogen Activator, Anticoagulant, Antiplatelet and Antihypertensive. The market is also segmented on the basis of application into Ischemic Stroke and Haemorrhagic Stroke. Geographically, the market is segmented across four regions namely Norh America, Europe, Asia Pacific, and LAMEA. Product launch is one of the few strategies adopted by leading market players. For instance, In March, 2015, FDA has approved WATCHMAN, a left atrial appendage closure device designed to prevent stroke in patients of atrial fibrillation. Silk Road Medical, Inc. has launched an Anti-Stroke Enroute Device, a transcarotid neuroprotection system, designed to access the common carotid artery by minimally invasive technique. KEY MARKET BENEFITS:
For more information about this report visit http://www.researchandmarkets.com/research/frq9j5/world_stroke View source version on businesswire.com: http://www.businesswire.com/news/home/20161028005538/en/ |